TD Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.7M | Sell |
2,034,930
-177,212
| -8% | -$4.07M | 0.04% | 334 |
|
|
2025
Q1 | $64.1M | Buy |
2,212,142
+371,856
| +20% | +$10.8M | 0.06% | 270 |
|
|
2024
Q4 | $68.3M | Sell |
1,840,286
-294,752
| -14% | -$10.9M | 0.06% | 258 |
|
|
2024
Q3 | $103M | Buy |
2,135,038
+443,469
| +26% | +$21.3M | 0.09% | 197 |
|
|
2024
Q2 | $67.7M | Buy |
1,691,569
+680,976
| +67% | +$27.2M | 0.06% | 254 |
|
|
2024
Q1 | $44.4M | Buy |
1,010,593
+217,034
| +27% | +$9.53M | 0.04% | 323 |
|
|
2023
Q4 | $49.1M | Buy |
793,559
+649,001
| +449% | +$40.1M | 0.05% | 294 |
|
|
2023
Q3 | $6.65M | Sell |
144,558
-13,500
| -9% | -$621K | 0.01% | 666 |
|
|
2023
Q2 | $9.08M | Buy |
158,058
+151,558
| +2,332% | +$8.71M | 0.01% | 619 |
|
|
2023
Q1 | $244K | Buy |
+6,500
| New | +$244K | ﹤0.01% | 1363 |
|
|
2022
Q3 | – | Sell |
-6,500
| Closed | -$226K | – | 1476 |
|
|
2022
Q2 | $226K | Buy |
+6,500
| New | +$226K | ﹤0.01% | 1375 |
|